Dashboard
Manage Tickers

ANGOANGIODYNAMICS INC

Nasdaq angiodynamics.com


$ 7.49 $ -0.08 (-0.99 %)    

Wednesday, 21-Aug-2024 12:15:22 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 480.31 $ -0.81 (-0.17 %)
DIA $ 407.93 $ -1.30 (-0.32 %)
SPY $ 558.73 $ -1.20 (-0.21 %)
TLT $ 98.89 $ 0.21 (0.21 %)
GLD $ 231.46 $ -0.20 (-0.09 %)
$ 7.57
$ 7.57
$ 7.49 x 111
$ 7.50 x 202
$ 7.47 - $ 7.58
$ 5.26 - $ 8.96
457,106
na
304.17M
$ 0.78
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-25-2024 05-31-2024 10-K
2 04-09-2024 02-29-2024 10-Q
3 01-08-2024 11-30-2023 10-Q
4 10-05-2023 08-31-2023 10-Q
5 08-03-2023 05-31-2023 10-K
6 03-31-2023 02-28-2023 10-Q
7 01-06-2023 11-30-2022 10-Q
8 10-11-2022 08-31-2022 10-Q
9 07-22-2022 05-31-2022 10-K
10 04-07-2022 02-28-2022 10-Q
11 01-07-2022 11-30-2021 10-Q
12 09-30-2021 08-31-2021 10-Q
13 07-27-2021 05-31-2021 10-K
14 03-31-2021 02-28-2021 10-Q
15 01-08-2021 11-30-2020 10-Q
16 10-07-2020 08-31-2020 10-Q
17 08-10-2020 05-31-2020 10-K
18 04-08-2020 02-29-2020 10-Q
19 01-08-2020 11-30-2019 10-Q
20 10-04-2019 08-31-2019 10-Q
21 07-25-2019 05-31-2019 10-K
22 04-02-2019 02-28-2019 10-Q
23 01-07-2019 11-30-2018 10-Q
24 10-01-2018 08-31-2018 10-Q
25 07-23-2018 05-31-2018 10-K
26 04-05-2018 02-28-2018 10-Q
27 01-05-2018 11-30-2017 10-Q
28 09-29-2017 08-31-2017 10-Q
29 08-04-2017 05-31-2017 10-K
30 04-03-2017 02-28-2017 10-Q
31 01-06-2017 11-30-2016 10-Q
32 10-05-2016 08-31-2016 10-Q
33 08-01-2016 05-31-2016 10-K
34 04-11-2016 02-29-2016 10-Q
35 01-08-2016 11-30-2015 10-Q
36 10-08-2015 08-31-2015 10-Q
37 08-10-2015 05-31-2015 10-K
38 04-09-2015 02-28-2015 10-Q
39 01-09-2015 11-30-2014 10-Q
40 10-15-2014 08-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

canaccord-genuity-maintains-buy-on-angiodynamics-lowers-price-target-to-13
Canaccord Genuity Maintains Buy on AngioDy...
07/17/2024 19:23:51

Canaccord Genuity analyst William Plovanic maintains AngioDynamics (NASDAQ:ANGO) with a Buy and lowers the price target from...

hc-wainwright--co-reiterates-buy-on-angiodynamics-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Angi...
07/17/2024 10:06:15

HC Wainwright & Co. analyst Yi Chen reiterates AngioDynamics (NASDAQ:ANGO) with a Buy and maintains $14 price target.

nasdaq-edges-lower-morgan-stanley-earnings-top-views
Nasdaq Edges Lower; Morgan Stanley Earning...
07/16/2024 18:31:51

medical-devices-maker-angiodynamics-lays-out-growth-plans-issues-upbeat-annual-guidance
Medical Devices Maker AngioDynamics Lays O...
07/16/2024 17:51:24

AngioDynamics reported a Q4 2024 adjusted EPS loss of $(0.05), beating the consensus of $(0.16). Sales rose 1.9% to $79.1 milli...

why-charles-schwab-shares-are-trading-lower-by-over-7-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Charles Schwab Shares Are Trading Lowe...
07/16/2024 17:06:26

crude-oil-down-1-bank-of-america-posts-upbeat-earnings
Crude Oil Down 1%; Bank of America Posts U...
07/16/2024 16:00:52

unitedhealth-posts-better-than-expected-earnings-joins-angiodynamics-bank-of-america--and-other-big-stocks-moving-higher-on-tuesday
UnitedHealth Posts Better-Than-Expected Ea...
07/16/2024 15:09:23

angiodynamics-forecasts-fiscal-year-2025-adjusted-eps-of-038-042-compared-to-fiscal-2024-pro-forma-adjusted-eps-of-045-versus-consensus-of-049
AngioDynamics Forecasts Fiscal Year 2025 A...
07/16/2024 10:48:40

angiodynamics-forecasts-fiscal-year-2025-sales-of-282m-288m-representing-growth-of-42--64-over-fiscal-2024-pro-forma-revenue-of-2707m-versus-consensus-of-28768m
AngioDynamics Forecasts Fiscal Year 2025 S...
07/16/2024 10:47:10

Med Tech net sales are expected to grow in the range of 10% to 12% Med Device net sales are expected to grow in the range of...

angiodynamics-q4-2024-adj-eps-005-beats-016-estimate-sales-71122m-beat-70891m-estimate
AngioDynamics Q4 2024 Adj EPS $(0.05) Beat...
07/16/2024 10:36:53

hc-wainwright--co-reiterates-buy-on-angiodynamics-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Angi...
05/22/2024 12:05:09

HC Wainwright & Co. analyst Yi Chen reiterates AngioDynamics (NASDAQ:ANGO) with a Buy and maintains $14 price target.

angiodynamics-secures-ce-mark-approval-in-europe-for-alphavac-f18-system
AngioDynamics Secures CE Mark Approval In ...
05/21/2024 21:34:24

The CE Mark for the AlphaVac F1885 System expands treatment options for healthcare professionals in the EU by offering a tool t...

angiodynamics-apex-av-trial-results-assessing-alphavac-f18-system-for-treatment-of-pulmonary-embolism-presented-at-scai-2024-scientific-sessions
AngioDynamics APEX-AV Trial Results Assess...
05/06/2024 20:47:25

New data finds AlphaVac F1885 System safe in patients with acute intermediate-risk pulmonary embolism (PE) and provides signifi...

insiders-buying-zumiez-and-3-other-stocks
Insiders Buying Zumiez And 3 Other Stocks
04/09/2024 11:29:06

Although U.S. stocks closed little changed on Monday, there were a few notable insider trades.

oppenheimer-upgrades-angiodynamics-to-outperform-announces-12-price-target
Oppenheimer Upgrades AngioDynamics to Outp...
04/05/2024 12:40:31

Oppenheimer analyst Steven Lichtman upgrades AngioDynamics (NASDAQ:ANGO) from Perform to Outperform and announces $12 price ...

medical-devices-focused-angiodynamics-unveils-upbeat-2024-financial-outlook-stock-soars
Medical Devices Focused AngioDynamics Unve...
04/04/2024 16:53:06

FDA grants 510(k) clearance to AngioDynamics' AlphaVac F1885 System for pulmonary embolism. Expanded indication broadens tr...

correction-angiodynamic-expects-fy2024-gross-margin-to-be-approximately-52-54-and-adjusted-eps-of-054-to-058-versus-consensus-of-043
CORRECTION: AngioDynamic Expects FY2024 Gr...
04/04/2024 16:13:57

angiodynamic-expects-fy2024-sales-of-270m-275m-reflects-picc-and-midline-businesses-divestiture-and-discontinuance-of-radiofrequency-ablation-and-syntrax-businesses-which-accounted-for-50m-of-prior-guidance-of-320m-325m-vs-consensus-of-31214m
Angiodynamic Expects FY2024 Sales Of $270M...
04/04/2024 11:06:18

angiodynamics-q3-adjusted-eps-016-misses-013-estimate-sales-7518m-miss-7573m-estimate
AngioDynamics Q3 Adjusted EPS $(0.16) Miss...
04/04/2024 11:02:30

AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.1...

angiodynamics-secures-510k-clearance-for-alphavac-f1885-system-in-treatment-of-pulmonary-embolism
AngioDynamics Secures 510(k) Clearance For...
04/04/2024 10:46:30

The expanded FDA indication allows for the utilization of the AlphaVac F1885 System for the treatment of PE, which broadens the...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION